Raymond Sanchez
2021
In 2021, Raymond Sanchez earned a total compensation of $3.4M as Chief Medical Officer at Cerevel Therapeutics Holdings, a 93% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $220,176 |
|---|---|
| Option Awards | $2,699,993 |
| Salary | $478,718 |
| Other | $17,400 |
| Total | $3,416,287 |
Sanchez received $2.7M in option awards, accounting for 79% of the total pay in 2021.
Sanchez also received $220.2K in non-equity incentive plan, $478.7K in salary and $17.4K in other compensation.
Rankings
In 2021, Raymond Sanchez's compensation ranked 3,919th out of 12,415 executives tracked by ExecPay. In other words, Sanchez earned more than 68.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,919 out of 12,415 | 68th |
Division Manufacturing | 1,606 out of 5,505 | 71st |
Major group Chemicals And Allied Products | 660 out of 2,375 | 72nd |
Industry group Drugs | 586 out of 2,096 | 72nd |
Industry Pharmaceutical Preparations | 409 out of 1,546 | 74th |
Source: SEC filing on April 28, 2022.
Sanchez's colleagues
We found five more compensation records of executives who worked with Raymond Sanchez at Cerevel Therapeutics Holdings in 2021.
2021
N Coles
Cerevel Therapeutics Holdings
Chief Executive Officer
2021
Abraham Ceesay
Cerevel Therapeutics Holdings
President
2021
Kathy Yi
Cerevel Therapeutics Holdings
Chief Financial Officer
2021
Scott Akamine
Cerevel Therapeutics Holdings
Chief Legal Officer
2021
Mark Bodenrader
Cerevel Therapeutics Holdings